You have 9 free searches left this month | for more free features.

Dominant Optic Atrophy

Showing 1 - 25 of 3,175

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

Not yet recruiting
  • Autosomal Dominant Optic Atrophy
  • +3 more
    • Sydney, Australia
      Sydney Eye Hospital
    Nov 15, 2023

    Nicotinamide Adverse Reaction Trial (Nicotinamide)

    Not yet recruiting
    • Nicotinamide Adverse Reaction
    • (no location specified)
    Aug 29, 2023

    Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

    Recruiting
    • Retinal Disease
    • +17 more
    • Arm 1
    • Westport, Connecticut
    • +2 more
    Nov 25, 2022

    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

    Recruiting
    • Rare Disorders
    • +309 more
      • Sioux Falls, South Dakota
      • +1 more
      Jun 20, 2022

      Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)

      Recruiting
      • Neurodegenerative Disease, Hereditary
      • +2 more
      • Mutation analysis
      • Buffalo, New York
        UBMD Pediatrics
      Mar 3, 2022

      Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)

      Recruiting
      • Neurodegenerative Disease, Hereditary
      • +2 more
      • Mutation analysis
      • Buffalo, New York
        UBMD Pediatrics
      Mar 3, 2022

      Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

      Not yet recruiting
      • Leber Hereditary Optic Neuropathy (LHON)
      • NFS-02 Injection
      • (no location specified)
      Apr 6, 2023

      Disease and Visual Disability on Quality of Life and Loss of

      Recruiting
      • Leber's Hereditary Optic Neuropathy (LHON)
        • Orléans, France
          Argo Sante
        Sep 22, 2022

        Trial

        Not yet recruiting
        • Leber Hereditary Optic Neuropathy (LHON)
        • NR082 Injection
        • Injection needle
        • (no location specified)
        Jan 30, 2023

        Optic Atrophy Trial in Alexandria (Systemic erythropoietin injection)

        Completed
        • Optic Atrophy
        • Systemic erythropoietin injection
        • Alexandria, Egypt
          Alexandria Faculty of Medicine
        Jul 11, 2021

        Wolfram Syndrome, Diabetes, Optic Nerve Atrophy Trial in Saint Louis (dantrolene sodium)

        Active, not recruiting
        • Wolfram Syndrome
        • +3 more
        • dantrolene sodium
        • Saint Louis, Missouri
          Washington University School of Medicine
        Feb 16, 2022

        Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber) Trial (GS010)

        Available
        • Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
        • GS010
        • (no location specified)
        Aug 2, 2021

        Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion, Hemianopia Trial in Iowa City (LSFG-NAVI)

        Recruiting
        • Ischemic Optic Neuropathy
        • +4 more
        • LSFG-NAVI
        • Iowa City, Iowa
          University of Iowa Department of Ophthalmology
        Jul 4, 2022

        Leber's Hereditary Optic Neuropathy (LHON) Trial in Beijing (NR082 injection, Sham Injection)

        Recruiting
        • Leber's Hereditary Optic Neuropathy (LHON)
        • NR082 injection
        • Sham Injection
        • Beijing, China
          Beijing Tongren Hospital, Capital Medical University
        Dec 21, 2021

        Eye Diseases, Retinitis Pigmentosa, Glaucoma Trial in St. John's (AlloRx)

        Recruiting
        • Eye Diseases
        • +6 more
        • AlloRx
        • St. John's, Antigua and Barbuda
          Medical Surgical Associates Center
        Jan 4, 2022

        Leber's Hereditary Optic Neuropathy Trial in Pasadena (elamipretide (MTP-131) 1% topical ophthalmic solution, Vehicle topical

        Completed
        • Leber's Hereditary Optic Neuropathy
        • elamipretide (MTP-131) 1% topical ophthalmic solution
        • Vehicle topical ophthalmic solution
        • Pasadena, California
          Doheny Eye Center
        Nov 29, 2021

        Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Sham)

        Completed
        • Leber Hereditary Optic Neuropathy
        • GS010
        • Sham
        • Pasadena, California
        • +6 more
        Jul 25, 2022

        Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay Trial in Saguenay (Rehabilitation)

        Recruiting
        • Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
        • Rehabilitation
        • Saguenay, Quebec, Canada
          Groupe de recherche interdisciplinaire sur les maladies neuromus
        Mar 3, 2023

        Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Placebo)

        Active, not recruiting
        • Leber Hereditary Optic Neuropathy
        • GS010
        • Placebo
        • Pasadena, California
        • +12 more
        Aug 2, 2022

        Safety Issues, Efficacy, Self Trial in Paris (Béfizal)

        Recruiting
        • Safety Issues
        • Efficacy, Self
        • Paris, France
          HEGP Hospital
        Feb 9, 2021

        Multiple Eye Fundus Diseases From Color Fundus Photograph

        Completed
        • Diabetic Retinopathy
        • +12 more
        • Software assisted imaging diagnosis
        • BeiJing, Beijing, China
        • +4 more
        Dec 28, 2021

        Leber's Hereditary Optic Neuropathy Trial in Miami (injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),, injection of scAAV2-P1ND4v2

        Active, not recruiting
        • Leber's Hereditary Optic Neuropathy
        • injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),
        • +3 more
        • Miami, Florida
          Bascom Palmer Eye Institute, University of Miami
        Jul 1, 2021

        Retinitis Pigmentosa, Leber's Hereditary Optic Neuropathy, Stargardt Disease Trial in Paris (Dynamic pupillometry sessions)

        Completed
        • Retinitis Pigmentosa
        • +2 more
        • Dynamic pupillometry sessions
        • Paris, France
          Centre Hospitalier National D'Ophtalùmologie des Quinze-Vingts
        May 28, 2021

        Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

        Not yet recruiting
        • Optic Pathway Glioma
        • Rome, Italy
          Catholic University, Policlinico A. Gemelli (Hospital)
        Feb 17, 2023

        Ocular Trauma Trial in Hangzhou (Tissue Plasminogen Activator)

        Recruiting
        • Ocular Trauma
        • Tissue Plasminogen Activator
        • Hangzhou, Zhejiang, China
          Second Affiliated Hospital, School of Medicine, Zhejiang Univers
        Feb 20, 2023